(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MGLL mRNA] CTD PMID:31150632 (S)-3,5-dihydroxyphenylglycine multiple interactions ISO RGD:737065 6480464 3, 5-dihydroxyphenylglycine inhibits the reaction [FMR1 gene mutant form results in increased activity of MGLL] CTD PMID:20393458 17alpha-ethynylestradiol increases expression ISO RGD:737065 6480464 Ethinyl Estradiol results in increased expression of MGLL mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:737065 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of MGLL mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:734078 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of MGLL mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:737065 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO RGD:734078 6480464 2 more ... CTD PMID:23146750 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:737065 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of MGLL mRNA more ... CTD PMID:16054899 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:737065 6480464 Tetrachlorodibenzodioxin results in increased expression of MGLL mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:737065 6480464 Tetrachlorodibenzodioxin affects the expression of MGLL mRNA CTD PMID:24680724 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MGLL mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MGLL mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of MGLL mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:737065 6480464 Tetrachlorodibenzodioxin results in decreased expression of MGLL mRNA CTD PMID:19465110 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of MGLL mRNA CTD PMID:21346803 2-arachidonoylglycerol increases abundance ISO RGD:737065 6480464 MGLL gene mutant form results in increased abundance of glyceryl 2-arachidonate CTD PMID:25030704 2-arachidonoylglycerol increases hydrolysis ISO RGD:737065 6480464 MGLL protein results in increased hydrolysis of glyceryl 2-arachidonate CTD PMID:18096503 , PMID:26209559 2-arachidonoylglycerol increases hydrolysis EXP 6480464 MGLL protein results in increased hydrolysis of glyceryl 2-arachidonate CTD PMID:21507991 2-arachidonoylglycerol multiple interactions EXP 6480464 [Chlorpyrifos results in decreased activity of MGLL protein] which results in increased abundance of glyceryl 2-arachidonate, JZL 184 inhibits the reaction [MGLL protein results in increased hydrolysis of glyceryl 2-arachidonate] CTD PMID:21507991 more ... 2-arachidonoylglycerol increases degradation ISO RGD:737065 6480464 MGLL protein results in increased degradation of glyceryl 2-arachidonate CTD PMID:25030704 2-arachidonoylglycerol multiple interactions ISO RGD:737065 6480464 [FMR1 gene mutant form results in increased activity of MGLL] which results in increased degradation of glyceryl 2-arachidonate, [JZL 184 results in decreased activity of MGLL protein] which results in increased abundance of glyceryl 2-arachidonate CTD PMID:20393458 more ... 2-oleoylglycerol increases degradation EXP 6480464 MGLL protein results in increased degradation of 2-oleoylglycerol CTD PMID:19515121 2-oleoylglycerol multiple interactions EXP 6480464 Nitroglycerin promotes the reaction [MGLL protein results in increased degradation of 2-oleoylglycerol] CTD PMID:19515121 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 3,4-dihydroxyphenylethyleneglycol affects response to substance ISO RGD:737065 6480464 MGLL protein affects the susceptibility to 3, 4-dihydroxyphenylglycol CTD PMID:21911610 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:737065 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mRNA] CTD PMID:16054899 4,4'-sulfonyldiphenol increases expression ISO RGD:737065 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MGLL mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MGLL mRNA CTD PMID:22504374 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of MGLL mRNA CTD PMID:24780913 aflatoxin B1 decreases expression ISO RGD:737065 6480464 Aflatoxin B1 results in decreased expression of MGLL mRNA CTD PMID:19770486 aflatoxin B1 increases methylation ISO RGD:734078 6480464 Aflatoxin B1 results in increased methylation of MGLL intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:734078 6480464 Aflatoxin B1 results in increased expression of MGLL mRNA CTD PMID:21641981 all-trans-retinoic acid decreases expression ISO RGD:734078 6480464 Tretinoin results in decreased expression of MGLL mRNA CTD PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MGLL mRNA CTD PMID:16483693 arsenite(3-) multiple interactions ISO RGD:737065 6480464 TRP53 protein affects the reaction [arsenite results in decreased expression of MGLL mRNA] CTD PMID:18929588 arsenite(3-) decreases expression ISO RGD:737065 6480464 arsenite results in decreased expression of MGLL mRNA CTD PMID:18929588 benzo[a]pyrene decreases expression ISO RGD:734078 6480464 Benzo(a)pyrene results in decreased expression of MGLL mRNA CTD PMID:20064835 benzo[a]pyrene decreases expression ISO RGD:737065 6480464 Benzo(a)pyrene results in decreased expression of MGLL mRNA CTD PMID:23735875 benzo[a]pyrene multiple interactions ISO RGD:737065 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA, AHR protein affects the reaction [Benzo(a)pyrene affects the expression of MGLL mRNA] CTD PMID:22228805 , PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:734078 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO RGD:737065 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA CTD PMID:27858113 Benzo[k]fluoranthene decreases expression ISO RGD:737065 6480464 benzo(k)fluoranthene results in decreased expression of MGLL mRNA CTD PMID:26377693 bezafibrate increases expression ISO RGD:737065 6480464 Bezafibrate results in increased expression of MGLL mRNA CTD PMID:17118139 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:737065 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 bis(2-ethylhexyl) phthalate increases expression ISO RGD:734078 6480464 Diethylhexyl Phthalate results in increased expression of MGLL mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate affects expression ISO RGD:737065 6480464 Diethylhexyl Phthalate affects the expression of MGLL mRNA CTD PMID:27405655 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MGLL mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of MGLL gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:737065 6480464 [Tetrachlorodibenzodioxin co-treated with 2 more ... CTD PMID:28433925 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of MGLL mRNA CTD PMID:24136188 cadmium atom increases expression ISO RGD:734078 6480464 Cadmium results in increased expression of MGLL mRNA CTD PMID:24376830 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MGLL mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:734078 6480464 Calcitriol results in increased expression of MGLL mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:734078 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MGLL mRNA CTD PMID:21592394 carbamazepine affects expression ISO RGD:734078 6480464 Carbamazepine affects the expression of MGLL mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:737065 6480464 Nanotubes, Carbon analog results in decreased expression of MGLL mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:737065 6480464 Nanotubes, Carbon analog results in increased expression of MGLL mRNA, Nanotubes, Carbon results in increased expression of MGLL mRNA CTD PMID:25620056 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of MGLL mRNA CTD PMID:18500788 chlorpyrifos decreases activity EXP 6480464 Chlorpyrifos results in decreased activity of MGLL protein CTD PMID:23761300 more ... chlorpyrifos multiple interactions ISO RGD:737065 6480464 Chlorpyrifos inhibits the reaction [Dietary Fats results in increased activity of MGLL protein] CTD PMID:29935250 chlorpyrifos multiple interactions EXP 6480464 [Chlorpyrifos results in decreased activity of MGLL protein] which results in increased abundance of glyceryl 2-arachidonate CTD PMID:23761300 , PMID:26642910 choline multiple interactions ISO RGD:737065 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MGLL mRNA CTD PMID:20938992 chrysene multiple interactions ISO RGD:737065 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO RGD:737065 6480464 Ciguatoxins affects the expression of MGLL mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:734078 6480464 Cisplatin results in decreased expression of MGLL mRNA CTD PMID:27594783 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of MGLL mRNA, Clofibrate results in increased expression of MGLL protein CTD PMID:12851107 more ... clofibrate multiple interactions ISO RGD:737065 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MGLL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MGLL mRNA] CTD PMID:17585979 clofibrate increases expression ISO RGD:737065 6480464 Clofibrate results in increased expression of MGLL mRNA CTD PMID:17585979 , PMID:30629241 cobalt dichloride decreases expression ISO RGD:734078 6480464 cobaltous chloride results in decreased expression of MGLL mRNA CTD PMID:19320972 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of MGLL mRNA CTD PMID:24386269 cocaine affects expression EXP 6480464 Cocaine affects the expression of MGLL mRNA CTD PMID:20187946 copper atom decreases expression EXP 6480464 Copper results in decreased expression of MGLL mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of MGLL mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO RGD:734078 6480464 Copper Sulfate results in decreased expression of MGLL mRNA CTD PMID:12860252 coumestrol multiple interactions ISO RGD:734078 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO RGD:734078 6480464 Coumestrol results in decreased expression of MGLL mRNA CTD PMID:19167446 cyclosporin A increases expression ISO RGD:734078 6480464 Cyclosporine results in increased expression of MGLL mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:737065 6480464 Cyclosporine results in decreased expression of MGLL mRNA CTD PMID:19770486 dexamethasone multiple interactions ISO RGD:737065 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of MGLL mRNA] CTD PMID:16054899 dexamethasone increases expression ISO RGD:734078 6480464 Dexamethasone results in increased expression of MGLL mRNA CTD PMID:25047013 dexamethasone decreases expression ISO RGD:737065 6480464 Dexamethasone results in decreased expression of MGLL mRNA CTD PMID:22733784 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MGLL mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:737065 6480464 Dichloroacetic Acid results in increased expression of MGLL mRNA CTD PMID:28962523 diclofenac decreases expression ISO RGD:737065 6480464 Diclofenac results in decreased expression of MGLL mRNA CTD PMID:26934552 dorsomorphin multiple interactions ISO RGD:734078 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:734078 6480464 Doxorubicin results in decreased expression of MGLL mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MGLL mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:734078 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of MGLL mRNA CTD PMID:19167446 ethanol increases expression ISO RGD:737065 6480464 Ethanol results in increased expression of MGLL mRNA CTD PMID:30319688 ethyl methanesulfonate decreases expression ISO RGD:734078 6480464 Ethyl Methanesulfonate results in decreased expression of MGLL mRNA CTD PMID:23649840 fenitrothion decreases activity ISO RGD:737065 6480464 Fenitrothion analog results in decreased activity of MGLL protein CTD PMID:16449251 fenofibrate increases expression ISO RGD:737065 6480464 Fenofibrate results in increased expression of MGLL mRNA CTD PMID:11798191 , PMID:17118139 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of MGLL mRNA CTD PMID:27665778 finasteride increases expression EXP 6480464 Finasteride results in increased expression of MGLL mRNA CTD PMID:24136188 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MGLL mRNA CTD PMID:24793618 folic acid affects expression ISO RGD:734078 6480464 Folic Acid affects the expression of MGLL mRNA CTD PMID:17320366 folic acid multiple interactions ISO RGD:737065 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MGLL mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:734078 6480464 Formaldehyde results in decreased expression of MGLL mRNA CTD PMID:23649840 , PMID:28937961 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of MGLL mRNA CTD PMID:27665778 genistein decreases expression ISO RGD:737065 6480464 Genistein results in decreased expression of MGLL mRNA CTD PMID:22553218 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of MGLL mRNA CTD PMID:24136188 glycerol increases chemical synthesis EXP 6480464 MGLL protein results in increased chemical synthesis of Glycerol CTD PMID:19515121 glycerol multiple interactions EXP 6480464 Nitroglycerin promotes the reaction [MGLL protein results in increased chemical synthesis of Glycerol] CTD PMID:19515121 graphite affects expression EXP 6480464 Graphite affects the expression of MGLL mRNA CTD PMID:29933104 indometacin affects expression ISO RGD:737065 6480464 Indomethacin affects the expression of MGLL mRNA CTD PMID:17546600 isoprenaline decreases expression ISO RGD:737065 6480464 Isoproterenol results in decreased expression of MGLL mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:737065 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MGLL mRNA CTD PMID:20938992 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of MGLL mRNA CTD PMID:24136188 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of MGLL mRNA CTD PMID:30467583 methimazole increases expression EXP 6480464 Methimazole results in increased expression of MGLL mRNA CTD PMID:22504374 methyl methanesulfonate decreases expression ISO RGD:734078 6480464 Methyl Methanesulfonate results in decreased expression of MGLL mRNA CTD PMID:23649840 mifepristone decreases expression EXP 6480464 Mifepristone results in decreased expression of MGLL mRNA CTD PMID:25972201 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:737065 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of MGLL mRNA CTD PMID:25566086 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of MGLL mRNA CTD PMID:24136188 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of MGLL mRNA CTD PMID:22110744 nickel sulfate increases expression ISO RGD:734078 6480464 nickel sulfate results in increased expression of MGLL mRNA CTD PMID:16780908 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of MGLL mRNA CTD PMID:24136188 nitroglycerin multiple interactions EXP 6480464 Nitroglycerin promotes the reaction [MGLL protein results in increased chemical synthesis of Glycerol], Nitroglycerin promotes the reaction [MGLL protein results in increased degradation of 2-oleoylglycerol] CTD PMID:19515121 nitroglycerin increases activity EXP 6480464 Nitroglycerin results in increased activity of MGLL protein CTD PMID:19515121 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MGLL mRNA CTD PMID:25729387 paracetamol multiple interactions ISO RGD:737065 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of MGLL mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of MGLL mRNA] CTD PMID:17585979 paracetamol decreases expression ISO RGD:734078 6480464 Acetaminophen results in decreased expression of MGLL mRNA CTD PMID:21420995 paracetamol affects expression ISO RGD:737065 6480464 Acetaminophen affects the expression of MGLL mRNA CTD PMID:17562736 parathion decreases activity EXP 6480464 Parathion results in decreased activity of MGLL protein CTD PMID:23933531 , PMID:26215119 PD 0325901 multiple interactions ISO RGD:734078 6480464 [(+)-JQ1 compound co-treated with PD 0325901] results in decreased expression of MGLL mRNA CTD PMID:25119042 PD 0325901 decreases expression ISO RGD:734078 6480464 PD 0325901 results in decreased expression of MGLL mRNA CTD PMID:25119042 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of MGLL mRNA CTD PMID:18692542 perfluorooctanoic acid increases expression ISO RGD:737065 6480464 perfluorooctanoic acid results in increased expression of MGLL mRNA CTD PMID:17681415 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of MGLL mRNA CTD PMID:16221955 , PMID:19162173 permethrin increases expression ISO RGD:737065 6480464 Permethrin results in increased expression of MGLL mRNA CTD PMID:30629241 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of MGLL mRNA CTD PMID:18158353 phenylmercury acetate increases expression ISO RGD:734078 6480464 Phenylmercuric Acetate results in increased expression of MGLL mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:734078 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA CTD PMID:27188386 phenylpropanolamine decreases expression ISO RGD:737065 6480464 Phenylpropanolamine results in decreased expression of MGLL mRNA CTD PMID:16465460 pirinixic acid multiple interactions ISO RGD:737065 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of MGLL mRNA, [pirinixic acid co-treated with PPARA] results in increased expression of MGLL mRNA CTD PMID:19710929 , PMID:20813756 pirinixic acid increases expression ISO RGD:737065 6480464 pirinixic acid results in increased expression of MGLL mRNA CTD PMID:11798191 more ... pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MGLL mRNA CTD PMID:19162173 more ... pravastatin decreases expression ISO RGD:737065 6480464 Pravastatin results in decreased expression of MGLL mRNA CTD PMID:27225895 pravastatin affects expression EXP 6480464 Pravastatin affects the expression of MGLL mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of MGLL mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:737065 6480464 propiconazole results in decreased expression of MGLL mRNA CTD PMID:21278054 Propiverine affects binding EXP 6480464 propiverine binds to MGLL protein CTD PMID:29273565 quercetin increases expression EXP 6480464 Quercetin results in increased expression of MGLL mRNA CTD PMID:18095365 quercetin decreases expression ISO RGD:737065 6480464 Quercetin results in decreased expression of MGLL mRNA CTD PMID:25862958 resveratrol multiple interactions ISO RGD:734078 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of MGLL mRNA CTD PMID:19167446 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of MGLL mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of MGLL mRNA CTD PMID:27900601 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MGLL mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:734078 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MGLL mRNA CTD PMID:27188386 sodium arsenite affects methylation ISO RGD:734078 6480464 sodium arsenite affects the methylation of MGLL gene CTD PMID:28589171 Soman decreases expression EXP 6480464 Soman results in decreased expression of MGLL mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of MGLL mRNA CTD PMID:25905778 sunitinib increases expression ISO RGD:734078 6480464 Sunitinib results in increased expression of MGLL mRNA CTD PMID:31533062 tacrolimus hydrate decreases expression ISO RGD:737065 6480464 Tacrolimus results in decreased expression of MGLL mRNA CTD PMID:25270620 tert-butyl hydroperoxide increases expression ISO RGD:734078 6480464 tert-Butylhydroperoxide results in increased expression of MGLL mRNA CTD PMID:15336504 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of MGLL mRNA CTD PMID:21515302 testosterone multiple interactions ISO RGD:734078 6480464 [Testosterone co-treated with Calcitriol] results in increased expression of MGLL mRNA CTD PMID:21592394 testosterone increases expression ISO RGD:734078 6480464 Testosterone results in increased expression of MGLL mRNA CTD PMID:21592394 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of MGLL mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MGLL mRNA CTD PMID:31150632 tetraphene multiple interactions ISO RGD:737065 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of MGLL mRNA CTD PMID:27858113 titanium dioxide decreases expression ISO RGD:737065 6480464 titanium dioxide results in decreased expression of MGLL mRNA CTD PMID:23557971 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of MGLL mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MGLL mRNA CTD PMID:25729387 triadimefon decreases expression ISO RGD:734078 6480464 triadimefon results in decreased expression of MGLL mRNA CTD PMID:26705709 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of MGLL mRNA CTD PMID:21683754 trichloroethene increases expression ISO RGD:737065 6480464 Trichloroethylene results in increased expression of MGLL mRNA CTD PMID:19448997 triphenyl phosphate increases expression ISO RGD:737065 6480464 triphenyl phosphate results in increased expression of MGLL mRNA CTD PMID:28163246 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of MGLL mRNA CTD PMID:21515302 trovafloxacin decreases expression EXP 6480464 trovafloxacin results in decreased expression of MGLL mRNA CTD PMID:24136188 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of MGLL mRNA CTD PMID:15885361 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of MGLL mRNA CTD PMID:24136188 valproic acid affects expression ISO RGD:737065 6480464 Valproic Acid affects the expression of MGLL mRNA CTD PMID:17292431 valproic acid increases expression ISO RGD:734078 6480464 Valproic Acid results in increased expression of MGLL protein CTD PMID:29501571 valproic acid decreases expression ISO RGD:734078 6480464 Valproic Acid results in decreased expression of MGLL mRNA CTD PMID:29501571 valproic acid increases methylation ISO RGD:734078 6480464 Valproic Acid results in increased methylation of MGLL gene CTD PMID:29154799 , PMID:29501571 vancomycin increases expression ISO RGD:737065 6480464 Vancomycin results in increased expression of MGLL mRNA CTD PMID:18930951 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of MGLL mRNA CTD PMID:19015723 WIN 55212-2 affects response to substance ISO RGD:737065 6480464 MGLL protein affects the susceptibility to Win 55212-2 CTD PMID:21911610 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of MGLL mRNA CTD PMID:27225895 zaragozic acid A affects expression ISO RGD:737065 6480464 squalestatin 1 affects the expression of MGLL mRNA CTD PMID:27225895 zearalenone multiple interactions ISO RGD:737065 6480464 [Zearalenone co-treated with CGA protein] results in decreased expression of MGLL protein CTD PMID:25058043
Gene-Chemical Interaction Annotations
